

Y300296 by Applied Biological Materials Inc. (ABM) is a monoclonal antibody targeting CD13 (Aminopeptidase N), a type II membrane zinc metallopeptidase expressed on myeloid progenitors, monocytes, granulocytes, and endothelial cells. Used in immunophenotyping and myeloid marker studies. Consult the lot-specific certificate of analysis for confirmed working applications and dilutions.